These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2016-005032-14 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients with Septic Shock. A Randomised, Double-blind, Two-stage, Placebo Controlled Study. 2018-06-13 due-trials
Listed as ongoing, but also has a completion date 2018-004827-36 Efficacy, Safety and Tolerability of Nangibotide in Patients with Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection Study. 2022-05-09 bad-data
Listed as ongoing, but also has a completion date 2020-001504-42 Efficacy and Safety Study Exploring Nangibotide Treatment in COVID-19 pAtients with ventiLatory support (ESSENTIAL). A randomized, double-blind, placebo-controlled study with adaptive features Estu... 2022-05-20 bad-data